These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32940599)

  • 1. MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression.
    Aikin TJ; Peterson AF; Pokrass MJ; Clark HR; Regot S
    Elife; 2020 Sep; 9():. PubMed ID: 32940599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.
    Kirouac DC; Du J; Lahdenranta J; Onsum MD; Nielsen UB; Schoeberl B; McDonagh CF
    PLoS Comput Biol; 2016 Apr; 12(4):e1004827. PubMed ID: 27035903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
    Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
    Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-Kinase dependent upregulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells.
    Kurrle N; Ockenga W; Meister M; Völlner F; Kühne S; John BA; Banning A; Tikkanen R
    BMC Cancer; 2013 Dec; 13():575. PubMed ID: 24304721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.
    Fernández IF; Blanco S; Lozano J; Lazo PA
    Mol Cell Biol; 2010 Oct; 30(19):4687-97. PubMed ID: 20679487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling.
    Shrestha Y; Schafer EJ; Boehm JS; Thomas SR; He F; Du J; Wang S; Barretina J; Weir BA; Zhao JJ; Polyak K; Golub TR; Beroukhim R; Hahn WC
    Oncogene; 2012 Jul; 31(29):3397-408. PubMed ID: 22105362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
    Kruger JS; Reddy KB
    Mol Cancer Res; 2003 Sep; 1(11):801-9. PubMed ID: 14517342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
    Wan PT; Garnett MJ; Roe SM; Lee S; Niculescu-Duvaz D; Good VM; Jones CM; Marshall CJ; Springer CJ; Barford D; Marais R;
    Cell; 2004 Mar; 116(6):855-67. PubMed ID: 15035987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response.
    Li Y; Roberts J; AkhavanAghdam Z; Hao N
    J Biol Chem; 2017 Dec; 292(50):20354-20361. PubMed ID: 29123025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.
    Saad MI; Alhayyani S; McLeod L; Yu L; Alanazi M; Deswaerte V; Tang K; Jarde T; Smith JA; Prodanovic Z; Tate MD; Balic JJ; Watkins DN; Cain JE; Bozinovski S; Algar E; Kohmoto T; Ebi H; Ferlin W; Garbers C; Ruwanpura S; Sagi I; Rose-John S; Jenkins BJ
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30833304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm.
    Brzezianska E; Pastuszak-Lewandoska D
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):422-39. PubMed ID: 21196179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile MAPK Signaling Modulates p53 Activity to Control Cell Fate Decisions at the G2 Checkpoint for DNA Damage.
    De S; Campbell C; Venkitaraman AR; Esposito A
    Cell Rep; 2020 Feb; 30(7):2083-2093.e5. PubMed ID: 32075732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
    Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review.
    Najafi M; Ahmadi A; Mortezaee K
    Cell Biol Int; 2019 Nov; 43(11):1206-1222. PubMed ID: 31136035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal signaling promotes a tumorigenic phenotype in human breast cancer.
    Kirsammer G; Strizzi L; Margaryan NV; Gilgur A; Hyser M; Atkinson J; Kirschmann DA; Seftor EA; Hendrix MJ
    Semin Cancer Biol; 2014 Dec; 29():40-50. PubMed ID: 25073112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.